z-logo
open-access-imgOpen Access
Sugammadex and Genaral Anesthesia in Two Pediatric Patients with Joubert Syndrome: Case Report
Author(s) -
Dilek Günay Canpolat,
Mustafa Yıldırım,
Salih Doğan,
Fatma Doğruel,
Hüseyin Per,
Mehmet Canpolat
Publication year - 2017
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2149-2247
DOI - 10.5152/etd.2017.16108
Subject(s) - medicine , joubert syndrome , sugammadex , anesthesia , rocuronium , propofol , cilium , biology , microbiology and biotechnology
Joubert syndrome (JS) is a rare genetic disorder that affects the cerebellum, controlling balance, and coordination, and it usually presents a molar tooth sign on magnetic resonance imaging. It is characterized by ataxia, an abnormal breathing pattern referred to as hyperpnea, sleep apnea, hypotonia, and abnormal eye and tongue movements. Because of sensitivity to respiratory depressant agents, including opiates, nitrous oxide, and neuromuscular blockers, and potential difficult airways, anesthetic management requires attention. Sugammadex binds to rocuronium and is a reverse neuromuscular blocker. In this study, two cases of JS where sugammadex was used for general anesthesia are presented. Sugammadex may be a safe general anesthetic for patients with JS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom